VIMTALABS638.50

Vimta Labs Limited

· Pharma & Health
₹ CrorePeersSUVENTAKEMcap ₹1,416 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY22
31/03/2022
FY23
31/03/2023
FY24
31/03/2024
Last 12M
31/12/2024
Non-current Assets
+ Property, Plant & Equipment149.8157.0156.4156.4
+ Capital Work-in-Progress12.358.658.6
+ Goodwill5.65.65.65.6
+ Other Intangibles13.412.29.19.1
+ Other Non-current Financial Assets2.53.12.82.8
Non-current Financial Assets2.53.12.82.8
+ Deferred Tax Assets2.14.37.87.8
+ Other Non-current Assets9.34.22.22.2
Total Non-current Assets182.8198.7242.5242.5
Current Assets
+ Inventories17.422.624.724.7
+ Trade Receivables76.980.087.087.0
+ Cash & Cash Equivalents10.830.513.413.4
+ Other Bank Balances9.312.312.3
+ Short-term Loans0.10.10.10.1
+ Other Current Financial Assets0.91.01.81.8
Current Financial Assets89.3120.9114.7114.7
+ Other Current Assets17.620.118.218.2
Total Current Assets124.4163.7157.6157.6
Total Assets307.2362.3400.1400.1
Equity
+ Equity Share Capital4.44.44.44.4
+ Other Equity / Reserves229.6277.4315.3315.3
Equity — Owners of Parent234.0281.8319.7319.7
Total Equity234.0281.8319.7319.7
Liabilities
+ Borrowings — Non-current12.79.99.19.1
Non-current Financial Liabilities12.79.99.19.1
+ Provisions — Non-current7.18.811.811.8
+ Deferred Tax Liabilities0.10.10.10.1
+ Other Non-current Liabilities5.64.55.35.3
Non-current Liabilities25.523.326.326.3
+ Borrowings — Current6.75.110.110.1
+ Trade Payables12.314.48.28.2
+ Other Current Financial Liab15.223.724.124.1
Current Financial Liabilities34.243.242.542.5
+ Provisions — Current3.64.03.43.4
+ Other Current Liabilities10.010.18.28.2
Current Liabilities47.757.354.154.1
Total Liabilities73.280.580.480.4
Total Equity & Liabilities307.2362.3400.1400.1
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY24 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.